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Abstract
Antisense oligonucleotides targeting microRNAs or their mRNA targets prove to be powerful tools for molecular biology
research and may eventually emerge as new therapeutic agents. Synthetic oligonucleotides are often contaminated with
highly homologous failure sequences. Synthesis of a certain oligonucleotide is difficult to scale up because it requires
expensive equipment, hazardous chemicals and a tedious purification process. Here we report a novel thermocyclic reaction,
polymerase-endonuclease amplification reaction (PEAR), for the amplification of oligonucleotides. A target oligonucleotide
and a tandem repeated antisense probe aresubjectedto repeatedcycles of denaturing, annealing, elongation and cleaving,in
which thermostable DNA polymerase elongation and strand slipping generate duplex tandem repeats, and thermostable
endonuclease (PspGI) cleavage releases monomeric duplex oligonucleotides. Each round of PEAR achieves over 100-fold
amplification. The product can be used in one more round of PEAR directly, and the process can be further repeated. In
addition to avoiding dangerous materials and improved product purity, this reaction is easy to scale up and amenable to full
automation. PEAR has the potential to be a useful tool for large-scale production of antisense oligonucleotide drugs.
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Introduction
MicroRNAs (miRNAs) are a family of short noncoding
regulatory RNA molecules. The miRNA pathway serves as an
important post-transcriptional regulation mechanism [1]. Synthetic
antisenseoligonucleotidestargetingmiRNAsortheirmRNAtargets
are proving to be powerful tools for molecular biology research [2]
andmay eventuallyfind applicationasnewtherapeuticagents[3,4].
Large quantities (from multi-grams to kilograms) of a specific
oligonucleotide have to be produced for commercial production of
antisense oligonucleotide drugs. Therefore, the development of an
economical and safe method for industrial production of short
oligonucleotides has become necessary. Traditional method for de
novo oligonucleotide synthesizing is the phosphodiester method [5].
Using automatic synthesizers, micrograms to kilograms of a specific
oligonucleotide can be produced in a few hours. Unfortunately,
synthetic oligonucleotides are often contaminated with a significant
fraction of truncated failure sequences, makes the product
purification process difficult. Moreover, the oligonucleotide synthesis
process requires not only expensive equipments, but also costly and
hazardous chemicals. For example, an organic solvent (dichloro-
methane or toluene) must be used to dissolve the deblocking reagent,
which arises the problem of disposing chemical wastes.
In modern molecular biology laboratories, nucleic acids are
routinely amplified by polymerase chain reaction (PCR). PCR has
the limitation, however, of needing a pair of synthetic primers. This
imposes not only a length constraint on the target DNA, but also a
yield limit on the PCR product defined by primer concentrations.
Therefore, PCR-based methods are generally not applicable for the
amplification of short oligonucleotides that are only approximately
20 nucleotides (nt) in length. Enzymatic amplification of oligonu-
cleotides has been reported by successive rounds of ligation, rolling
circle replication (RCR) and cleaving [6] or nicking [7], but a
laborious recircularization process is required for each round of
RCR. Here we report a novel thermocyclic reaction, polymerase-
endonuclease amplification reaction (PEAR), for amplification of
oligonucleotides. In addition to avoid using hazardous chemicals
and improving product purity, this reaction is easy to scale up
and amenable to full automation, thus enabling large-scale and
pollution-free antisense oligonucleotide production.
The Principle of PEAR
A PEAR reaction contains a target oligonucleotide (X), an
antisense probe, a thermostable DNA polymerase (such as Taq
polymerase), a thermostable restriction endonuclease (such as
PspGI), four dNTPs and an appropriate buffer solution. The
PLoS ONE | www.plosone.org 1 January 2010 | Volume 5 | Issue 1 | e8430antisense probe, denoted by X9R9X9, is designed to be a single-
stranded oligonucleotide containing at least two tandem repeated
complements of the target sequence (X9) that are separated from
one another by an intervening complementary recognition site (R9)
for PspGI.
As shown in Fig 1, PEAR consists of repetitive cycles of: (1)
heat denaturation, (2) annealing, (3) elongation, and (4) cleaving.
In the first cycle, a target oligonucleotide and an antisense probe
were heat-denatured and annealed to form a partial duplex (X/
X9R9X9). When a target oligonucleotide binds to a probe in the
upstream (Fig 1, top right), there is no elongation, because it
provides no primer/template structure for the Taq polymerase.
However, as both target and probe are present in a large number
of copies, according to the law of probability, nearly half of the
target oligonucleotides bind to the probe in the downstream. In
the presence of dNTPs, they are elongated by Taq DNA
polymerase to form fully matched duplex tandem repeats (XRX/
X9R9X9). Subsequently, PspGI cleavage of the recognition site
releases monomeric oligonucleotides (X/X9). Thereafter, a next
cycle of denaturation, annealing, elongation and cleaving is
started again, resulting in exponential amplification of the duplex
oligonucleotide.
In addition, the tandem repeated duplexes are not fully digested
by PspGI, because the duration of cleavage is rather short. When
the remaining tandem repeated duplexes are subjected to more
cycles of denaturing, reannealing and elongation, the number of
repeat units increases continuously through slipped strand pairing
and DNA polymerase elongation (Fig 1, right). When PspGI
cleavage monomerizes the elongated tandem repeats in a following
cycle, many more duplex oligonucleotides are released. It is this
slipping-and-cleaving mechanism that promotes not only the rate of
amplification, but also the yield of product. Moreover, the PEAR
products can be used in a next round of PEAR amplification
directly without any treatment, and the process can be further
repeated. The tandem repeated oligonucleotides are thus called
seeds, because they can reproduce themselves.
Results
Implementation of PEAR
A synthetic oligonucleotide and an antisense probe derived from
human microRNA miR-375 were used to validate the proposed
reaction mechanism. PEAR reactions with complete and incom-
plete (lacking Taq DNA polymerase, PspGI or target) components
were conducted under previously optimized reaction conditions
with target concentration at 1 nM and probe concentration at
100 nM. As shown in Fig 2, a lower band represents the duplex
product X/X9 and several upper bands represent tandem repeats
are observed in the complete PEAR reactions, but such bands are
not observed if any of the four essential components, the two
enzymes, the target and the probe, is omitted. We further tested
another three pairs of targets and antisense probes, and the
amplifications are all dependent on the presence of two enzymes,
the target, and the probe (data not shown).
Figure 1. Schematic description of PEAR. Sense and antisense strands are represented by solid and dashed lines respectively, the 39 ends are
indicated by arrows and the restriction sites for PspGI are indicated by solid diamonds. When a target oligonucleotide (X) binds to a probe in the
upstream, it is elongated by the Taq DNA polymerase, and a full-duplex oligonucleotide containing tandem repeats is produced. If the repeats are
cleaved by PspGI, short duplex oligos (X/X9) are released; and when they are not cleaved, the number of tandem repeats increases by slipping and
elongation.
doi:10.1371/journal.pone.0008430.g001
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conducted with target concentrations ranging from 0.1 pM to
1 nM and probe concentration at 100 nM. As shown in Fig 3, the
yield is very high when target concentration was at 0.1 to 1 nM,
whereas relatively low when target concentration was less than
10 pM.
Hpy99I Digestion of the PEAR Product
Although duplex oligonucleotides showed increased cellular
uptake when compared to single-stranded (ss) antisense oligonu-
cleotides [8], and demonstrated improved in vitro potency and
stability compared to small interfering RNA [9], single-stranded
antisense oligonucleotides have been more frequently used in
practical applications [10–13]. Therefore, it is necessary to
separate the antisense oligonucleotides from its complementary
strands. To facilitate the separation of the two complementary
strands, we introduced a recognition site for restriction enzyme
Hpy99I into the probe positioned between the tandem repeats and
downstream to the recognition site for PspGI. At the end of PEAR,
PspGI cleavage of the product has resulted in a 5-nt overhang in
the 59-end of the sense strand. After PEAR amplification, the
products were pooled and further digested with Hpy99I, resulting
in another 5-nt overhang in the 39-end of the sense strand (Fig 4).
It is noted that the antisense strand is cleaved into 20-nt
monomers, and the sense strand is cleaved into monomers that
are 25 or 30 nt in length, which allows convenient separation by
chromatographic methods.
Separation and Analysis of the Antisense
Oligonucleotides
Forseparationofthe antisenseoligonucleotides,weused ananion
exchange chromatography using a SOURCE 15Q column [14].
The high pH stability of SOURCE 15Q allows facile separation of
the antisense oligonucleotides from its complementary strands
under denaturing alkaline conditions at pH 12. The chromatogram
shown in Fig 5 represents the purification of 1 nmol of antisense
oligonucleotides. The antisense fraction was collected within the
window indicated in Fig 5. The 20-nt antisense oligonucleotides
were separated from the sense strands, short by-products and
remaining tandem repeats. Collected fraction was further analyzed
by anion exchange chromatography and capillary electrophoresis.
As shown in Fig 6, the purity of the collected fraction analysis by
chromatography was .99.0%. Fig 7 shows analysis of purified
antisense oligonucleotide by capillary electrophoresis. The purity
was confirmed to be better than 99.0%. The purity level of this
oligonucleotide product is significantly improved when compared to
that of HPLC-purified synthetic oligonucleotides [14]. This is
primarily due to the avoiding of highly homologous impurities,
especially (n-1) deletions. Further analysis by Electrospray mass
spectrometry (ESI-MS) proved that the structure of the purified
product is correct (Fig 8).
Scale-Up and Productivity Evaluation
PEAR reactions were run in 96-well plates, with 956100 mL
PEAR reactions and a no target control (NTC) in each run. To
demonstrate the ability to scale up, three successive rounds of
PEAR were conducted, at scales of 1, 100 and 500 runs,
respectively. The product of round 1 was used diluted 1:100 as
seeds for round 2 directly without any treatment, and that of
round 2 for round 3. After cleavage and purification, the quantity
of purified antisense oligonucleotide was given by measuring its
optical density at a wavelength of 260 nm. The average
concentrations, purities, yields and total yields of recoverable
(purified) products are estimated and summarized in Table 1. On
average, the concentration of purified product is about 10 mMo r
70 ng/ml, which is ,100-fold higher than the input concentra-
tions. The average yield of purified product of a single run is about
0.67 mg, which is greater than the typical yield of HPLC-purified
product of a 1-mmole scale commercial synthesis. The total yield of
round 2 (a 100-fold scale-up of round 1) was increased to ,67 mg;
and that of round 3 (a 5-fold scale-up of round 2), was further
increased to ,336 mg, indicating that this method is well suited
for scaling up.
Discussion
MiRNAs plays an important role in post-transcriptional gene
silencing that is highly conserved among species [1]. Synthetic
Figure 2. PEAR reactions with complete and incomplete
components. Target (X) and probe (X9R9X9R9X9) concentrations were
at 1nM and 100 nM respectively. For PspGI, H and L stand for high
(0.4 U/mL) and low (0.1 U/mL) concentrations respectively. Lane M:
Invitrogen Trackit
TM 10 bp DNA ladder; Lane 1–2: complete PEAR
reactions containing Taq DNA polymerase, PspGI, the target and the
probe. The lower band (shown by an arrow) represents the 20-bp
duplex monomers, and the upper bands represent tandem repeats;
Lane 3–9: incomplete PEAR reactions lacking one or both enzymes or
the target. No product band was observed. The bands represent probe
self-dimerization formed by intermolecular interactions.
doi:10.1371/journal.pone.0008430.g002
Figure 3. PEAR reactions with different target concentrations.
Lane M: Invitrogen Trackit
TM 10 bp DNA ladder; lane 2–8: PEAR reaction
with 1 to 10
24 nM of input oligonucleotides. The lower band (shown by
an arrow) represents the 20-bp duplex monomers, and the upper bands
represent tandem repeats; Probe (X9R9X9R9X9) concentration is at
100 nM. A final incubation at 75uC for 30 min was conducted to cleave
the product.
doi:10.1371/journal.pone.0008430.g003
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mRNAs have been proved to be powerful tools to specifically
and selectively regulate gene expression, and to investigate the
roles of dysregulated genes in human diseases [2]. MiR-375, for
example, is highly expressed in pancreatic islets and is required for
glucose homeostasis. This miRNA is conserved among zebrafish,
mice and human [15,16]. Obese mice exhibit increased miR-375
expression, and genetic deletion of miR-375 resulted in a severe
diabetes [17]. Targeted inhibition of miRNA with a modified
antisense oligonucleotide reveals the important role for miR-375 in
pancreatic islet [18].
Antisense oligonucleotides to target miRNAs or mRNA are
expected to be capable of curing a wide variety of human diseases,
including cancer, obesity, cardiovascular and metabolic diseases
[3,4] and viral infections [19]. By far, antisense oligonucleotides
are all manufactured by solid-support phosphoramidite-coupling
chemistry [8–14]. Dichloromethane (CH2Cl2), a halogenated
solvent, was used to dissolve the deblocking reagent (trichloroa-
cetic acid, TCA, or dichloroacetic acid, DCA). As oligonucleotide
synthesizers are now available for syntheses in large scale, the
quantity of chlorinated waste generated becomes quite large [20].
Typically, crude products from solid-support organic synthesis
are contaminated with a significant fraction of highly homologous
failure sequences that arise from incomplete detritylation,
coupling, sulfurization, capping or deprotection [21]. The most
significant impurities found in synthetic oligonucleotides are the
(n-1) deletions that differ from the full-length product by lacking
only one of the desired nucleotides. For oligonucleotides 18–21
nucleotides in length, it is difficult to remove the (n-1) deletions
completely from full-length oligonucleotides by HPLC [21].
As a novel and simple method for the amplification of short
oligonucleotides, PEAR is capable of solving all of the problems
mentioned above. The basic raw materials, nucleotides and
enzymes, are all safe and pollution-free. Hence, although a small-
scale synthesis of the seeds is still a prerequisite step, the use of
hazardous chemicals is reduced to a minimum. Moreover,
purification of the PEAR amplified oligonucleotide product is
quite routine and easy. The purity level of the product is also
improved due to avoiding of (n-1) deletions. The error rate of
different DNA polymerases has effects on the mutational rate of
amplified large DNA fragments. Since the error rates of these
thermostable DNA polymerases are very low (typically ranging
from 10
24 for Taq DNA polymerase to 10
26 for high fidelity
thermostable DNA polymerases), and the target oligonucleotides
amplified in PEAR is very short, the error rate of thermostable
DNA polymerases should have minimal effects on the fidelity of
the amplified DNA.
For the majority of existing DNA amplification technologies,
including polymerase chain reaction (PCR) [22], ligase chain
reaction (LCR) [23], rolling circle amplification (RCA) [24],
loop-mediated isothermal amplification (LAMP) [25], strand
displacement amplification (SDA) [26] and helicase-dependent
amplification (HDA) [27], they all need a pair of short synthetic
primers to achieve exponential amplification. The yields of the
final products are inherently dependent on and limited by the
input primer concentrations.
Figure 4. Double digestion of the PEAR product by PspGI and Hpy99I. The sense and the antisense strand are indicated respectively by (+)
and (2). Recognition sites for PspGI and Hpy99I are underlined and marked. Each position where cleavage is expected to occur is indicated by a caret
(‘‘ˆ
’’). The antisense strands (A) are black boxed, the sense strands (B and C) are boxed, and the by-products (D and E) are grey boxed. The expected
length for each strand is indicated in parenthesis.
doi:10.1371/journal.pone.0008430.g004
Figure 5. HPLC separation and purification of antisense
oligonucleotide. Fractions are indicated by letter A to E as shown
in Fig. 4. Fraction A, which contains the antisense strands, was collected
in the indicated interval. Sample preparation: 10 mg PEAR product
double digested by PspGI and Hpy99I; Column: SOURCE Q PE 4.6/100;
Flow rate: 1 ml/min; Buffer A: 10 mM NaOH, pH 12; Buffer B: 10 mM
NaOH+2M NaCl, pH 12; Gradient: 20–35% B in 50 column volume.
doi:10.1371/journal.pone.0008430.g005
Figure 6. Analytical HPLC analysis of purified antisense
oligonucleotide. Sample preparation: 25 mL purified antisense oligo-
nucleotide; Column: DNAPac PA-100 (4/250); Flow rate: 1 ml/min; Buffer
A: 10 mM NaClO4+1 mM Tris; Buffer B: 300 mM NaClO4+1 mM Tris;
Gradient: 10–70% B, 7.6 CV.
doi:10.1371/journal.pone.0008430.g006
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reaction that can achieve 10
6-fold amplification of a target
oligonucleotide in a short time (less than 10 min) [28]. However
the utility of EXPAR is currently limited, as serious nonspecific
background amplification was reported [29]. Moreover, obviously
in EXPAR DNA synthesis proceeds in only one of the two strands
(the target strand), but not in the other (the antisense strand), so the
product yield is still limited by the input concentration of the
antisense template.
Noteworthy, rolling-circle replication (RCR) that proceeds in a
linear fashion using the highly processive phi29 DNA polymerase
can copy a circular probe into a DNA strand containing .1,000
tandem repeated complements of a circularized DNA molecule.
Circle-to-circle amplification (C2CA) [6], a multi-step RCR-based
process for strand-specific amplification of circularized DNA, has
been used for the amplification of DNA circles, in which tandem
repeated complements of DNA circles are generated by RCR, and
converted to monomeric circles of opposite polarity to that of the
starting material. Billion-fold amplifications were achieved
through successive rounds of ligation, RCR and cleaving.
However, a laborious cleavage, ligation and recircularization
process are required for each round of RCR amplification.
Moreover, a synthetic ligation template is required to recircularize
and monomerize the tandem repeated complements, so this
technique requires the additional production of large amounts of
ligation templates. This problem was eliminated by using a
hairpin-containing self-templating oligonucleotide that contains a
suicide cassette, a recognition site for a nicking enzyme, and
recircularizing and monomerizing the tandem repeated comple-
ments by nicking the suicide cassette [7]. But a laborious nicking,
ligation and recircularization process is still needed for each
generation of RCR, making it not readily amenable to
automation.
In contrast, PEAR is a simple but effective method for the
amplification of short oligonucleotides through the unique
slipping-and-cleaving mechanism. PEAR uses much less expensive
thermocyclers instead of highly expensive DNA synthesizers, so it
has the potential to be a useful tool for large-scale production of
antisense oligonucleotide drugs. One round of PEAR amplifica-
tion can result in over 100-fold increment in product yield as
evidenced from the data presented here. We have observed more
than 1000-fold increment in PEAR reactions (data not show), but
we adopted a one hundred-fold amplification for the scale-up
reactions in this study, because it provides more reliable and
uniform product yield. Three rounds of PEAR starting from
micrograms of seeds produced more than three hundred
milligrams of products. Thus more rounds of PEAR starting from
these hundred-milligram seeds can yield dozen-grams, and then
kilograms, of products. Thus, one hundred-fold scale-up is
sufficient for large-scale oligonucleotide production.
In this preliminary study, we demonstrated only the production
of an unmodified antisense oligonucleotide. Modified antisense
oligonucleotides, such as phosphorothioate oligodeoxynucleotides
[19], 29-O-methoxyethyl [10–12], 29-O-methyl [11–12] or 29-
fluoro substituted oligonucleotides [11–12], and locked nucleic
acid [11–13], are reported to demonstrate increased stability and
potency when compared to its native counterparts. Previously,
modified DNA bearing 5(methoxycarbonylmethyl)-29-deoxyuridin
has been prepared in large scale by PCR and post-synthetic
derivatization [30]. LNA-modified DNA has been prepared by
primer elongation [31,32], PCR and in vitro transcription [33]. The
utilization of PEAR technology for the preparation of modified
oligonucleotides still needs further study and optimization.
We have tested a number of other thermostable restriction
endonucleases such as ApeKI and PhoI that can survive through
repeated cycles of high temperature. We found that PspGI is the
best choice for PEAR reaction. The enzymatic properties of PspGI
have been studied extensively [34,35]. We are in the process of
evaluating a number of different thermostable DNA polymerases
such as DyNAzyme II Hot start DNA polymerase and Phusion
DNA polymerase that carry the 39-59 proof-reading activity and
lack the template-independent terminal transferase activity.
Materials and Methods
Enzymes and Oligonucleotides
Taq DNA Polymerase, PspGI and Hpy99I, were purchased
from New England Biolabs (NEB), Inc. A target oligonucleotide
and two antisense probes targeting human microRNA miR-375
were custom synthesized and HPLC-purified by Invitrogen Life
technologies. The sequence of the target oligonucleotide is 59-
TGT TCG TTC GGC TCG CGT GA-39. Both of the two
probes contain three tandem repeated complements of the target
sequence (X9). The first probe (X9R9X9R9X9) was used for
validation of the reaction mechanism, in which the three
complements are separated from each other by a recognition site
(R9) for PspGI. The second probe (X9R9H9X9R9H9X9) was used in
the scale-up reactions, in which two recognition sites (R9 and H9),
respectively for PspGI and Hpy99I, are embedded between the
Figure 7. Capillary electrophoresis of HPLC purified antisense
oligonucleotide. Capillary: 50 mm618 cm, filled with polyacrylamide
cyclodextrin gel; Buffer: Tris-borate/Urea; Running conditions: 1.5 kV/
30 min; Sample application: 1 kV/5 s.
doi:10.1371/journal.pone.0008430.g007
Figure 8. ESI Mass spectrum analysis of HPLC purified
antisense oligonucleotide. Calculated molecular weight is 6105.0
Daltons, the measured molecular weight is 6105.5 Daltons.
doi:10.1371/journal.pone.0008430.g008
PEAR Production of Oligos
PLoS ONE | www.plosone.org 5 January 2010 | Volume 5 | Issue 1 | e8430repeats. The sequence of the first probe is 59-TCA CGC GAG
CCG AAC GAA CAC CAG GTC ACG CGA GCC GAA CGA
ACA CCA GGT CAC GCG AGC CGA ACG AAC A-39, and
that of the second probe is 59-TCA CGC GAG CCG AAC GAA
CAC CAG GTT TTC GAC GTC ACG CGA GCC GAA CGA
ACA CCA GGT TTT CGA CGT CAC GCG AGC CGA ACG
AAC A-39. The purity of the target oligonucleotide and probes
received was ,95.0%. They were further purified in our
own lab by anion exchange chromatography to achieve .99.0%
purity.
PEAR Reactions
PEAR were carried out in 96-well plates on an Applied
Biosystems 9700 Thermal Cycler, each in a 100 mL volume
reaction mixture containing 200 mM each dNTP, 15 mM Tris-
HCl, 30 mM KCl, 5 mM (NH4)2SO4, 2.5 mM MgCl2, 0.02%
BSA, 0.08 u/ml Taq DNA polymerase, 0.4 u/ml PspGI restriction
enzyme, desired amount of target oligonucleotide and antisense
probe. The reactions were initiated at 95uC for 1 min, followed by
30 cycles of denaturing at 94uC for 15 sec, annealing at 55uC for
35 sec, elongation and cleaving at 75uC for 5 min. If it is
necessary, PspGI digestion of the product is conducted by a final
incubation at 75uC for 30 min. PEAR products were separated by
15% non-denaturing polyacrylamide gel electrophoresis (PAGE),
and visualized under an ultraviolet illuminator after SYBR Gold
staining (Molecular Probes).
Cleavage, Separation, Purification and Quantification
The PEAR products were pooled and fully digested by the
addition of 1 volume of cleavage mixture containing 16NEBuffer
4, and 1.0 u/ml of Hpy99I. Cleavage reactions were incubated for
3 hours at 37uC and stopped by heat inactivation at 65uC for
20 minutes. Alternatively, in order to remove BSA, Taq DNA
polymerases and excess dNTPs, PEAR products were phenol
extracted, ethanol precipitated, washed three times with 75%
ethanol, dried and resuspended in ddH2O, and double digested by
the addition of 1 volume of cleavage mixture containing 16
NEBuffer 4, and 1.0 u/ml each of Hpy99I and PspGI. Cleavage
reactions were incubated for 3 hours at 37uC and 30 minutes at
75uC. Separation and purification of the antisense oligonucleotide
were performed by anion exchange chromatography using A ¨KTA
explorer
TM 10 system (GE Healthcare) as described [14].
SOURCE Q PE 4.6/100 prepacked analytical columns filled
with polymer-based, 15 mm monosized beads were purchased
from GE Healthcare. The column effluent was fractionated and
collected using a Frac-950 Fraction Collector (GE Healthcare).
The volume of collected fraction was 0.5 column volume (CV).
The chromatographic conditions are described in the legend to
Fig 5. A HiPrep
TM 26/10 column (GE Healthcare) was employed
for desalting the purified oligonucleotide using MilliQ
TM ultrapure
water (Millipore Corporation, Billerica, USA) as eluent. The mass
estimates of the purified antisense oligonucleotide were given by
260 nm absorbance measurements of diluted samples. The data
were analyzed in Microsoft Excel.
Purity Analysis
The purity of purified antisense oligonucleotide was analyzed
by anion exchange chromatography as described [14]. The anion
exchange HPLC analysis was conducted on Hewlett-Packard
Model 1100 liquid chromatography (Palo Alto, CA, USA) fitted
with a non-porous medium DNAPac PA-100 4/250 mm analyt-
ical column (Dionex Corporation, Sunnyvale, CA, USA),
thermostatted to 25C and operated at a flow rate of 480 cm/h.
The chromatographic conditions are described in the legend to
Fig 6.
Capillary electrophoresis was performed using a 50-mm
I.D.620-cm (effective length 18 cm) capillary. The capillary was
treated with PlusOne
TM Bind-Silane (GE Healthcare) and filled
with polyacrylamide cyclodextrin gel. Buffer was consisted of
0.1 M Tris-0.25 M boric acid, pH 8.5, containing 7 M urea.
Injection was made at 1 kV for 5 sec. Analysis was performed at
1.5 kV for 30 min.
Electrospray Mass Spectrometry (ESI-MS) Analysis
Mass spectrometry analyses were performed on a VG Platform
II mass spectrometer (Fisons Instrument) as described in [36]. The
N2 nebulizing gas was maintained at 100 p.s.i., with a 5.0 l/min
flow as drying gas. The HPLC-purified oligonucleotide product
was brought up in a 90:9:1 methanol:H2O:NH4OH solution at a
concentration of 5 pmol/ml. Samples were infused utilizing a
Harvard Instruments Syringe Infusion Pump 22 at a flow rate of
10 ml/min. Tests were performed in the negative ionization mode
and the ESI source temperature was kept at 120C. Fifteen
continuum scans were averaged in the ‘MCA’ mode over the mass
to charge range (m/z) 300–1700.
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Table 1. Average recoverable concentration, purity and yield of the purified antisense oligonucleotide.
Round#a Runsb Average recoverable concentration Purityd Recoverable Yield (mg)
(mM) (ng/ml ) Average Total
11
c 10.543 70.966 99.18% 0.674 0.674
2 100 10.579 71.209 99.17% 0.676 67.649
3 500 10.524 70.840 99.17% 0.673 336.490
aThe product of round 1 was used as seeds for round 2, and that of round 2 for round 3.
bEach run consisted of 956100 ml reactions. Target and probe concentration are at 1 nM and 100 nM respectively.
cRound 1 had two duplicate runs. As the first run had been used as seeds, the second run was used for purification and analysis.
dPurity was calculated as peak area % at UV 260 nm.
doi:10.1371/journal.pone.0008430.t001
PEAR Production of Oligos
PLoS ONE | www.plosone.org 6 January 2010 | Volume 5 | Issue 1 | e8430References
1. Ambros V (2004) The functions of animal microRNAs. Nature 431: 350–355.
2. Esau CC (2008) Inhibition of microRNA with antisense oligonucleotides.
Methods 44(1): 55–60.
3. Weiler J, Hunziker J, Hall J (2006) Anti-miRNA oligonucleotides (AMOs):
ammunition to target miRNAs implicated in human disease? Gene Ther 13(6):
496–502.
4. Rayburn ER, Zhang R (2008) Antisense, RNAi, and Gene Silencing Strategies
for Therapy: Mission Possible or Impossible? Drug Discov Today 13(11-12):
513–521.
5. Brown EL, Belagaje R, Ryan MJ, Khorana HG (1979) Chemical synthesis and
cloning of a tyrosine tRNA gene. Methods Enzymol 68: 109–151.
6. Dahl F, Bane ´r J, Gullberg M, Mendel-Hartvig M, Landegren U, et al. (2004)
Circle-to-circle amplification for precise and sensitive DNA analysis. Proc Natl
Acad Sci U S A 101(13): 4548–53.
7. Lohmann JS, Stougaard M, Koch J (2007) A new enzymatic route for
production of long 59-phosphorylated oligonucleotides using suicide cassettes
and rolling circle DNA synthesis. BMC Biotechnol 7: 49.
8. Astriab-Fisher A, Fisher MH, Juliano R, Herdewijn P (2004) Increased uptake of
antisense oligonucleotides by delivery as double stranded complexes. Biochem
Pharmacol 68: 403–407.
9. Allerson CR, Sioufi N, Jarres R, Prakash TP, Naik N, et al. (2005) Fully 29-
Modified Oligonucleotide Duplexes with Improved in Vitro Potency and
Stability Compared to Unmodified Small Interfering RNA. J Med Chem 48:
901–904.
10. Butler M, Hayes CS, Chappell A, Murray SF, Yaksh TL, et al. (2005) Spinal
distribution and metabolism of 29-O-(2-methoxyethyl)-modified oligonucleotides
after intrathecal administration in rats. Neuroscience 131 (3): 705–715.
11. Davis S, Propp S, Freier SM, Jones LE, Serra MJ, et al. (2009) Potent inhibition
of microRNA in vivo without degradation. Nucleic Acids Res 37(1): 70–77.
12. Davis S, Lollo B, Freier S, Esau CC (2006) Improved targeting of miRNA with
antisense oligonucleotides. Nucleic Acids Res 34 (8): 2294–2304.
13. Lu Y, Xiao J, Lin H, Bai Y, Luo X, et al. (2009) A single anti-microRNA
antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers
an improved approach for microRNA interference. Nucleic Acids Res 37(3):
e24. Available: http://nar.oxfordjournals.org/cgi/content/abstract/gkn1053v1.
Accessed 2009 Sep 1.
14. Shanagar J (2005) Purification of a synthetic oligonucleotide by anion exchange
chromatography: method optimisation and scale-up. Biochem Biophys Methods
64(3): 216–25.
15. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, et al. (2004) A pancreatic
islet-specific microRNA regulates insulin secretion. Nature 432: 226–230.
16. Avnit-Sagi T, Kantorovich L, Kredo-Russo S, Hornstein E, Walker MD (2009)
The promoter of the pri-miR-375 gene directs expression selectively to the
endocrine pancreas. PLoS One 4(4): e5033. Available: http://www.plosone.org/
article/info:doi%2F10.1371%2Fjournal.pone.0005033. Accessed 2009 Sep 1.
17. Poy MN, Hausser J, Trajkovski M, Braun M, Collins S, et al. (2009) MiR-375
maintains normal pancreatic alpha- and beta-cell mass. Proc Natl Acad Sci U S A
106(14): 5813–5818.
18. Kloosterman WP, Lagendijk AK, Ketting RF, Moulton JD, Plasterk RH (2007)
Targeted inhibition of miRNA maturation with morpholinos reveals a role for
miR-375 in pancreatic islet development. PLoS Biol 5: e203. Available: http://
www.plosbiology.org/article/info: doi%2F10.1371%2Fjournal.pbio.0050203.
Accessed 2009 Sep 1.
19. Balotta C, Lusso P, Crowley R, Gallo RC, Franchini G (1993) Antisense
phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human
immunodeficiency virus type 1 replication in primary human macrophages.
J Virol 67(7): 4409–4414.
20. Krotz AH, Carty RL, Scozzari AN, Cole DL, Ravikumar VT (2000) Large-
Scale Synthesis of Antisense Oligonucleotides without Chlorinated Solvents. Org
Process Res Dev 4: 190–193.
21. Gilar M (2001) Analysis and Purification of Synthetic Oligonucleotides by
Reversed-Phase High-Performance Liquid Chromatography with Photodiode
Array and Mass Spectrometry Detection. Ana Biochem 298: 196–206.
22. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, et al. (1985) Enzymatic
amplification of beta-globin genomic sequences and restriction site analysis for
diagnosis of sickle cell anemia. Science 230 (4732): 1350–1354.
23. Barany F (1991) Genetic disease detection and DNA amplification using cloned
thermostable ligase. Proc Natl Acad Sci U S A 88(1): 189–193.
24. Lizardi PM, Huang X, Zhu Z, Bray-Ward P, Thomas DC, et al. (1998)
Mutation detection and single-molecule counting using isothermal rolling-circle
amplification. Nat Genet 19(3): 225–232.
25. Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, et al. (2000)
Loop-mediated isothermal amplification of DNA. Nucleic Acids Res 28: E63.
Available: http://nar.oxfordjournals.org/cgi/content/short/28/12/e63. Ac-
cessed 2009 Sep 1.
26. Walker GT, Little MC, Nadeau JG, Shank DD (1992) Isothermal in vitro
amplification of DNA by a restriction enzyme/DNA polymerase system. Proc
Natl Acad Sci U S A 89(1): 392–396.
27. Vincent M, Xu Y, Kong H (2004) Helicase-dependent isothermal DNA
amplification. EMBO rep 5(8): 795–800.
28. Van Ness J, Van Ness LK, Galas DJ (2003) Isothermal reactions for the
amplification of oligonucleotides. Proc Natl Acad Sci U S A 100 (8): 4504–4509.
29. Tan E, Erwin B, Dames S, Ferguson T, Buechel M, et al. (2008) Specific versus
nonspecific isothermal DNA amplification through thermophilic polymerase and
nicking enzyme activities. Biochemistry 47(38): 9987–9999.
30. Mehedi Masud M, Ozaki-Nakamura A, Kuwahara M, Ozaki H, Sawai H (2003)
Modified DNA bearing 5(methoxycarbonylmethyl)-29-deoxyuridine: prepara-
tion by PCR with thermophilic DNA polymerase and postsynthetic derivatiza-
tion. Chembiochem 4(7): 584–588.
31. Veedu RN, Vester B, Wengel J (2007) In vitro incorporation of LNA
nucleotides. Nucleosides Nucleotides Nucleic Acids 26(8–9): 1207–1210.
32. Veedu RN, Vester B, Wengel J (2008) Polymerase chain reaction and
transcription using locked nucleic acid nucleotide triphosphates. J Am Chem
Soc 130(26): 8124–8125.
33. Veedu RN, Vester B, Wengel J (2009) Enzymatic synthesis of LNA-modified
DNA duplexes using KOD DNA polymerase. Org Biomol Chem 7(7):
1404–1409.
34. Pingoud V, Conzelmann C, Kinzebach S, Sudina A, Metelev V, et al. (2003)
PspGI, a type II restriction endonuclease from the extreme thermophile
Pyrococcus sp.: structural and functional studies to investigate an evolutionary
relationship with several mesophilic restriction enzymes. J Mol Biol 329(5):
913–929.
35. Morgan R, Xiao J, Xu S (1998) Characterization of an extremely thermostable
restriction enzyme, PspGI, from a Pyrococcus strain and cloning of the PspGI
restriction-modification system in Escherichia coli. Appl Environ Microbiol
64(10): 3669–3673.
36. Castleberry CM, Rodicio LP, Limbach PA (2008) Electrospray ionization mass
spectrometry of oligonucleotides. Curr Protoc Nucleic Acid Chem. John Wiley &
Sons, Inc 35: 10.2.1–10.2.19.
PEAR Production of Oligos
PLoS ONE | www.plosone.org 7 January 2010 | Volume 5 | Issue 1 | e8430